Bioventus Inc (BVS)
11.71
+0.20
(+1.74%)
USD |
NASDAQ |
Nov 22, 16:00
11.76
+0.05
(+0.43%)
After-Hours: 20:00
Bioventus Cash from Financing (Quarterly): 0.362M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.362M |
| June 30, 2024 | -7.845M |
| March 31, 2024 | -4.242M |
| December 31, 2023 | -0.014M |
| September 30, 2023 | 8.229M |
| June 30, 2023 | -62.25M |
| March 31, 2023 | 27.38M |
| December 31, 2022 | -5.438M |
| September 30, 2022 | 50.65M |
| June 30, 2022 | 7.655M |
| March 31, 2022 | 9.205M |
| Date | Value |
|---|---|
| December 31, 2021 | 176.31M |
| September 30, 2021 | -4.346M |
| June 30, 2021 | -6.117M |
| March 31, 2021 | 107.53M |
| December 31, 2020 | -9.878M |
| September 30, 2020 | -57.12M |
| June 30, 2020 | -11.36M |
| March 31, 2020 | 48.78M |
| March 31, 2016 | 5.495M |
| March 31, 2015 | 3.852M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-62.25M
Minimum
Jun 2023
176.31M
Maximum
Dec 2021
14.08M
Average
-0.014M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Insulet Corp | 7.80M |
| Perspective Therapeutics Inc | 0.628M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 10.32M |
| Cash from Investing (Quarterly) | -0.064M |
| Free Cash Flow | 29.05M |
| Free Cash Flow Per Share (Quarterly) | 0.1571 |
| Free Cash Flow to Equity (Quarterly) | 9.947M |
| Free Cash Flow to Firm (Quarterly) | 20.95M |
| Free Cash Flow Yield | 3.88% |